Meeting
2018 ASCO Annual Meeting
Impact of somatic mutations on recurrence free survival (RFS) and overall survival (OS) for resected non-small cell lung cancer (NSCLC): results from the Japan Molecular Epidemiology for lung cancer study (JME).
Authors
Akihiro Tamiya
National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan
Akihiro Tamiya , Yasuhiro Koh , Akihito Kubo , Masahiko Ando , Shun-ichi Isa , Hideo Saka , Naoki Yoshimoto , Masakuni Serizawa , Sadanori Takeo , Hirofumi Adachi , Tsutomu Tagawa , Osamu Kawashima , Motohiro Yamashita , Kazuhiko Kataoka , Yukito Ichinose , Yukiyasu Takeuchi , Katsuya Watanabe , Akihide Matsumura , Tomoya Kawaguchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8549)
DOI
10.1200/JCO.2018.36.15_suppl.8549
Abstract #
8549
Poster Bd #
155
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2023 ASCO Annual Meeting
Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets.
First Author: Akiko Tateishi
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2022 ASCO Annual Meeting
Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non–small cell lung cancers.
First Author: Xiaoru Tian